Difficulty: Medium
Average Score: 78%
Practice
The primary objective for designing drugs that selectively inhibit COX-2 is to
Correct answer
C
Rationale
In pharmacology, understanding the rationale behind designing drugs that selectively inhibit COX-2 is crucial for safe and effective patient care. The correct answer is C) Lower the risk of gastrointestinal toxicity.
Selective COX-2 inhibitors were developed to target inflammation while minimizing the gastrointestinal side effects associated with non-selective NSAIDs. COX-2 is induced at sites of inflammation and mediates pain and inflammation, while COX-1 maintains gastric mucosa integrity. By selectively inhibiting COX-2, drugs can reduce inflammation without disrupting the protective functions of COX-1 in the stomach, thus lowering the risk of gastrointestinal toxicity such as ulcers and bleeding.
Option A) Decrease the risk of nephrotoxicity is incorrect because COX-2 inhibition can actually increase the risk of renal side effects due to the role of COX-2 in renal homeostasis. Option B) Improve anti-inflammatory effectiveness is not the primary objective of COX-2 inhibitors, as their main goal is to reduce side effects. Option D) Reduce the cost of treatment of rheumatoid arthritis is unrelated to the mechanism of action of COX-2 inhibitors.
Educationally, grasping the rationale behind COX-2 selective inhibitors enhances pharmacological knowledge, prescribing accuracy, and patient safety. It emphasizes the importance of balancing therapeutic benefits with potential adverse effects when selecting pharmacological interventions, ultimately leading to more effective and tailored patient care.
Selective COX-2 inhibitors were developed to target inflammation while minimizing the gastrointestinal side effects associated with non-selective NSAIDs. COX-2 is induced at sites of inflammation and mediates pain and inflammation, while COX-1 maintains gastric mucosa integrity. By selectively inhibiting COX-2, drugs can reduce inflammation without disrupting the protective functions of COX-1 in the stomach, thus lowering the risk of gastrointestinal toxicity such as ulcers and bleeding.
Option A) Decrease the risk of nephrotoxicity is incorrect because COX-2 inhibition can actually increase the risk of renal side effects due to the role of COX-2 in renal homeostasis. Option B) Improve anti-inflammatory effectiveness is not the primary objective of COX-2 inhibitors, as their main goal is to reduce side effects. Option D) Reduce the cost of treatment of rheumatoid arthritis is unrelated to the mechanism of action of COX-2 inhibitors.
Educationally, grasping the rationale behind COX-2 selective inhibitors enhances pharmacological knowledge, prescribing accuracy, and patient safety. It emphasizes the importance of balancing therapeutic benefits with potential adverse effects when selecting pharmacological interventions, ultimately leading to more effective and tailored patient care.